Jason McCarthy
Stock Analyst at Maxim Group
(1.25)
# 3,555
Out of 4,944 analysts
165
Total ratings
30.22%
Success rate
-10.58%
Average return
Main Sectors:
Stocks Rated by Jason McCarthy
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AKTX Akari Therapeutics, | Initiates: Buy | $5 | $1.02 | +390.20% | 1 | Jul 18, 2025 | |
SLS SELLAS Life Sciences Group | Maintains: Buy | $4 → $7 | $1.61 | +334.78% | 4 | Jul 16, 2025 | |
INMB INmune Bio | Maintains: Buy | $30 → $8 | $2.42 | +230.58% | 2 | Jul 2, 2025 | |
KZIA Kazia Therapeutics | Maintains: Buy | $15 | $8.50 | +76.47% | 3 | Jun 11, 2025 | |
CTXR Citius Pharmaceuticals | Downgrades: Hold | n/a | $1.30 | - | 1 | May 23, 2025 | |
BNGO Bionano Genomics | Upgrades: Buy | $8 | $3.08 | +159.74% | 2 | May 20, 2025 | |
MTVA MetaVia | Maintains: Buy | $6 → $3 | $0.63 | +375.06% | 1 | May 19, 2025 | |
CERO CERo Therapeutics Holdings | Initiates: Buy | $60 | $7.97 | +652.82% | 1 | May 19, 2025 | |
CLRB Cellectar Biosciences | Downgrades: Hold | n/a | $4.61 | - | 2 | May 14, 2025 | |
PMN ProMIS Neurosciences | Initiates: Buy | $3 | $0.70 | +328.57% | 1 | May 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $20 | $2.24 | +792.86% | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.43 | - | 2 | May 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.12 | +257.14% | 1 | Mar 27, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.57 | - | 2 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 | $0.66 | +504.14% | 3 | Mar 25, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $3.04 | +228.95% | 1 | Mar 21, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.86 | +248.72% | 2 | Mar 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.25 | +1,532.65% | 1 | Feb 24, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $5.30 | +126.42% | 2 | Jan 30, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $1.78 | +742.70% | 2 | Jan 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.46 | +1,421.74% | 5 | Jan 10, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $110 | $72.30 | +52.14% | 2 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $224 → $140 | $8.24 | +1,599.03% | 2 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $120.02 | - | 7 | Nov 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $1.83 | +227.87% | 1 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $12 | $4.22 | +184.36% | 2 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.48 | - | 4 | Oct 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $25 | $2.77 | +802.53% | 1 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $25 | $8.04 | +210.95% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $25 | $11.76 | +112.59% | 2 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $14.85 | -19.19% | 5 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $10 | $6.20 | +61.29% | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $5 | $1.51 | +231.13% | 2 | Aug 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $10 | $0.68 | +1,370.59% | 2 | May 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.42 | +613.78% | 1 | May 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $4.13 | +45.28% | 1 | Apr 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.10 | - | 2 | Nov 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.92 | - | 1 | Nov 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.13 | - | 4 | Sep 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.53 | +553.59% | 1 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $3.19 | +1,153.92% | 1 | Sep 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 | $2.86 | +948.95% | 4 | Sep 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 | $1.42 | +3,280.28% | 5 | Jul 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $10 | $1.70 | +488.24% | 2 | May 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $12 | $0.73 | +1,542.04% | 2 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $387.77 | +3.15% | 4 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $35.90 | - | 2 | Mar 29, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.70 | +841.18% | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $60 | $4.25 | +1,311.76% | 2 | Mar 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $8 | $2.44 | +227.87% | 1 | Nov 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.94 | - | 1 | Nov 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.49 | - | 5 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.44 | - | 3 | Oct 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $5 | $0.63 | +697.19% | 1 | Aug 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.40 | - | 1 | Aug 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.73 | +584.93% | 1 | Jun 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.73 | - | 4 | May 26, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $0.70 | +12,775.54% | 2 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $900 | $2.50 | +35,900.00% | 1 | Jan 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $4.44 | +5,311.50% | 1 | Nov 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.63 | - | 1 | Nov 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $224 | $2.75 | +8,045.45% | 1 | Oct 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.18 | - | 4 | Oct 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4,180 | $10.24 | +40,720.31% | 1 | Sep 15, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4,500 | $1.07 | +420,460.75% | 1 | Jun 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $10.15 | +786.70% | 1 | Jun 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $360 | $3.70 | +9,629.73% | 1 | May 20, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.24 | +29.87% | 1 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.25 | - | 4 | Mar 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.30 | +1,053.85% | 1 | Mar 10, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $80 | $2.32 | +3,348.28% | 3 | Feb 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $9.68 | - | 3 | Jan 7, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $170 | $31.67 | +436.79% | 1 | Nov 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $5.22 | +168.20% | 1 | Jul 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.77 | - | 2 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $0.86 | +4,551.70% | 2 | Oct 16, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $16.76 | -28.40% | 3 | Jul 27, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $48 | $2.01 | +2,288.06% | 1 | Jun 22, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $39.86 | -64.88% | 2 | Jun 1, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $12 | $24.02 | -50.04% | 2 | May 11, 2018 |
Akari Therapeutics,
Jul 18, 2025
Initiates: Buy
Price Target: $5
Current: $1.02
Upside: +390.20%
SELLAS Life Sciences Group
Jul 16, 2025
Maintains: Buy
Price Target: $4 → $7
Current: $1.61
Upside: +334.78%
INmune Bio
Jul 2, 2025
Maintains: Buy
Price Target: $30 → $8
Current: $2.42
Upside: +230.58%
Kazia Therapeutics
Jun 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.50
Upside: +76.47%
Citius Pharmaceuticals
May 23, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.30
Upside: -
Bionano Genomics
May 20, 2025
Upgrades: Buy
Price Target: $8
Current: $3.08
Upside: +159.74%
MetaVia
May 19, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.63
Upside: +375.06%
CERo Therapeutics Holdings
May 19, 2025
Initiates: Buy
Price Target: $60
Current: $7.97
Upside: +652.82%
Cellectar Biosciences
May 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $4.61
Upside: -
ProMIS Neurosciences
May 12, 2025
Initiates: Buy
Price Target: $3
Current: $0.70
Upside: +328.57%
May 8, 2025
Maintains: Buy
Price Target: $10 → $20
Current: $2.24
Upside: +792.86%
May 8, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.43
Upside: -
Mar 27, 2025
Initiates: Buy
Price Target: $4
Current: $1.12
Upside: +257.14%
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $6.57
Upside: -
Mar 25, 2025
Upgrades: Buy
Price Target: $4
Current: $0.66
Upside: +504.14%
Mar 21, 2025
Initiates: Buy
Price Target: $10
Current: $3.04
Upside: +228.95%
Mar 10, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.86
Upside: +248.72%
Feb 24, 2025
Initiates: Buy
Price Target: $4
Current: $0.25
Upside: +1,532.65%
Jan 30, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $5.30
Upside: +126.42%
Jan 16, 2025
Maintains: Buy
Price Target: $8 → $15
Current: $1.78
Upside: +742.70%
Jan 10, 2025
Upgrades: Buy
Price Target: $7
Current: $0.46
Upside: +1,421.74%
Nov 15, 2024
Maintains: Buy
Price Target: $60 → $110
Current: $72.30
Upside: +52.14%
Nov 13, 2024
Maintains: Buy
Price Target: $224 → $140
Current: $8.24
Upside: +1,599.03%
Nov 8, 2024
Downgrades: Hold
Price Target: n/a
Current: $120.02
Upside: -
Nov 7, 2024
Initiates: Buy
Price Target: $6
Current: $1.83
Upside: +227.87%
Nov 1, 2024
Maintains: Buy
Price Target: $22 → $12
Current: $4.22
Upside: +184.36%
Oct 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.48
Upside: -
Oct 25, 2024
Upgrades: Buy
Price Target: $25
Current: $2.77
Upside: +802.53%
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $25
Current: $8.04
Upside: +210.95%
Sep 24, 2024
Maintains: Buy
Price Target: $18 → $25
Current: $11.76
Upside: +112.59%
Sep 24, 2024
Upgrades: Buy
Price Target: $12
Current: $14.85
Upside: -19.19%
Aug 6, 2024
Maintains: Buy
Price Target: $8 → $10
Current: $6.20
Upside: +61.29%
Aug 6, 2024
Maintains: Buy
Price Target: $30 → $5
Current: $1.51
Upside: +231.13%
May 9, 2024
Maintains: Buy
Price Target: $4 → $10
Current: $0.68
Upside: +1,370.59%
May 6, 2024
Initiates: Buy
Price Target: $3
Current: $0.42
Upside: +613.78%
Apr 3, 2024
Upgrades: Buy
Price Target: $6
Current: $4.13
Upside: +45.28%
Nov 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.10
Upside: -
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.92
Upside: -
Sep 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.13
Upside: -
Sep 12, 2023
Initiates: Buy
Price Target: $10
Current: $1.53
Upside: +553.59%
Sep 12, 2023
Initiates: Buy
Price Target: $40
Current: $3.19
Upside: +1,153.92%
Sep 5, 2023
Maintains: Buy
Price Target: $30
Current: $2.86
Upside: +948.95%
Jul 24, 2023
Upgrades: Buy
Price Target: $48
Current: $1.42
Upside: +3,280.28%
May 18, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $1.70
Upside: +488.24%
May 3, 2023
Maintains: Buy
Price Target: $30 → $12
Current: $0.73
Upside: +1,542.04%
May 3, 2023
Maintains: Buy
Price Target: $325 → $400
Current: $387.77
Upside: +3.15%
Mar 29, 2023
Downgrades: Hold
Price Target: n/a
Current: $35.90
Upside: -
Mar 10, 2023
Initiates: Buy
Price Target: $16
Current: $1.70
Upside: +841.18%
Mar 9, 2023
Maintains: Buy
Price Target: $30 → $60
Current: $4.25
Upside: +1,311.76%
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $8
Current: $2.44
Upside: +227.87%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.94
Upside: -
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.49
Upside: -
Oct 12, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.44
Upside: -
Aug 23, 2022
Maintains: Buy
Price Target: $8 → $5
Current: $0.63
Upside: +697.19%
Aug 17, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.40
Upside: -
Jun 17, 2022
Initiates: Buy
Price Target: $5
Current: $0.73
Upside: +584.93%
May 26, 2022
Downgrades: Hold
Price Target: n/a
Current: $4.73
Upside: -
May 23, 2022
Reiterates: Buy
Price Target: $90
Current: $0.70
Upside: +12,775.54%
Jan 19, 2022
Initiates: Buy
Price Target: $900
Current: $2.50
Upside: +35,900.00%
Nov 29, 2021
Initiates: Buy
Price Target: $240
Current: $4.44
Upside: +5,311.50%
Nov 19, 2021
Downgrades: Hold
Price Target: n/a
Current: $7.63
Upside: -
Oct 29, 2021
Initiates: Buy
Price Target: $224
Current: $2.75
Upside: +8,045.45%
Oct 4, 2021
Downgrades: Hold
Price Target: n/a
Current: $4.18
Upside: -
Sep 15, 2021
Initiates: Buy
Price Target: $4,180
Current: $10.24
Upside: +40,720.31%
Jun 28, 2021
Initiates: Buy
Price Target: $4,500
Current: $1.07
Upside: +420,460.75%
Jun 28, 2021
Initiates: Buy
Price Target: $90
Current: $10.15
Upside: +786.70%
May 20, 2021
Initiates: Buy
Price Target: $360
Current: $3.70
Upside: +9,629.73%
Apr 19, 2021
Initiates: Buy
Price Target: $12
Current: $9.24
Upside: +29.87%
Mar 29, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.25
Upside: -
Mar 10, 2021
Initiates: Buy
Price Target: $15
Current: $1.30
Upside: +1,053.85%
Feb 16, 2021
Maintains: Buy
Price Target: $14 → $80
Current: $2.32
Upside: +3,348.28%
Jan 7, 2021
Upgrades: Buy
Price Target: n/a
Current: $9.68
Upside: -
Nov 19, 2020
Initiates: Buy
Price Target: $170
Current: $31.67
Upside: +436.79%
Jul 8, 2020
Initiates: Buy
Price Target: $14
Current: $5.22
Upside: +168.20%
Dec 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $0.77
Upside: -
Oct 16, 2018
Maintains: Buy
Price Target: $60 → $40
Current: $0.86
Upside: +4,551.70%
Jul 27, 2018
Maintains: Buy
Price Target: $10 → $12
Current: $16.76
Upside: -28.40%
Jun 22, 2018
Maintains: Buy
Price Target: $52 → $48
Current: $2.01
Upside: +2,288.06%
Jun 1, 2018
Maintains: Buy
Price Target: $8 → $14
Current: $39.86
Upside: -64.88%
May 11, 2018
Maintains: Buy
Price Target: $9 → $12
Current: $24.02
Upside: -50.04%